JP2023531508A5 - - Google Patents
Info
- Publication number
- JP2023531508A5 JP2023531508A5 JP2022579666A JP2022579666A JP2023531508A5 JP 2023531508 A5 JP2023531508 A5 JP 2023531508A5 JP 2022579666 A JP2022579666 A JP 2022579666A JP 2022579666 A JP2022579666 A JP 2022579666A JP 2023531508 A5 JP2023531508 A5 JP 2023531508A5
- Authority
- JP
- Japan
- Prior art keywords
- approximately
- hboc
- preparation
- weight
- supplement
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063042668P | 2020-06-23 | 2020-06-23 | |
| US63/042,668 | 2020-06-23 | ||
| PCT/US2021/038606 WO2021262803A1 (en) | 2020-06-23 | 2021-06-23 | Compositions and methods for treating hemorrhagic shock |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2023531508A JP2023531508A (ja) | 2023-07-24 |
| JP2023531508A5 true JP2023531508A5 (enExample) | 2024-07-01 |
Family
ID=79281812
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022579666A Pending JP2023531508A (ja) | 2020-06-23 | 2021-06-23 | 出血性ショックを処置するための組成物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230241184A1 (enExample) |
| EP (2) | EP4782058A2 (enExample) |
| JP (1) | JP2023531508A (enExample) |
| AU (1) | AU2021297879A1 (enExample) |
| CA (1) | CA3183555A1 (enExample) |
| ES (1) | ES3073540T3 (enExample) |
| WO (1) | WO2021262803A1 (enExample) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025091017A1 (en) * | 2023-10-27 | 2025-05-01 | Ohio State Innovation Foundation | Synthetic whole blood substitutes |
| US12419850B1 (en) | 2024-03-21 | 2025-09-23 | GanD, Inc. | Bioactive fluid compositions |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4001401A (en) * | 1975-02-02 | 1977-01-04 | Alza Corporation | Blood substitute and blood plasma expander comprising polyhemoglobin |
| CA1312009C (en) | 1986-11-10 | 1992-12-29 | Carl W. Rausch | Extra pure semi-synthetic blood substitute |
| US5084558A (en) | 1987-10-13 | 1992-01-28 | Biopure Corporation | Extra pure semi-synthetic blood substitute |
| US5955581A (en) | 1986-11-10 | 1999-09-21 | Biopure Corporation | Method for producing a stable polymerized hemoglobin blood-substitute |
| US5650388A (en) | 1989-11-22 | 1997-07-22 | Enzon, Inc. | Fractionated polyalkylene oxide-conjugated hemoglobin solutions |
| US5407579A (en) | 1993-07-02 | 1995-04-18 | National Science Council | Hemoglobin purification |
| US5895810A (en) | 1995-03-23 | 1999-04-20 | Biopure Corporation | Stable polymerized hemoglobin and use thereof |
| US5585484A (en) | 1995-04-19 | 1996-12-17 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | Hemoglobin crosslinkers |
| US5691453A (en) | 1995-06-07 | 1997-11-25 | Biopure Corporation | Separation of polymerized hemoglobin from unpolymerized hemoglobin on hydroxyapatite using HPLC |
| JP3664328B2 (ja) | 1996-01-19 | 2005-06-22 | 富士写真フイルム株式会社 | 血漿または血清試料の調製方法 |
| CA2254223A1 (en) | 1998-11-16 | 2000-05-16 | Biophys, Inc. | Device and method for analyzing a biologic sample |
| US6518010B2 (en) * | 2001-02-28 | 2003-02-11 | Biopure Corporation | Use of defibrinated blood for manufacture of a hemoglobin-based oxygen carrier |
| US7144989B2 (en) | 2002-03-25 | 2006-12-05 | Albert Einstein College Of Medicine Of Yeshiva University | Pegylated non-hypertensive hemoglobins, methods of preparing same, and uses thereof |
| US7135554B1 (en) * | 2004-01-27 | 2006-11-14 | Biopure Corporation | Method of forming a polymerized hemoglobin solution from stabilized hemoglobin |
| EP1958618A1 (de) | 2007-02-15 | 2008-08-20 | Octapharma AG | Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren |
| TWI332813B (en) | 2007-05-11 | 2010-11-01 | Unimicron Technology Corp | Process of structure with embedded circuit |
| WO2009102895A2 (en) | 2008-02-12 | 2009-08-20 | Amicus Therapeutics, Inc. | Method to predict response to pharmacological chaperone treatment of diseases |
| BRPI1006722A2 (pt) | 2009-04-09 | 2017-10-10 | Entegrion Inc | "método de preparação de hemoderivados desidratado, hemoderivados desidratados, bandagem ou auxílio cirúrgico, método para a preparação de plaquetas sanguíneas fixas desidratadas, plaquetas sanguíneas fixas desidratadas, método para o tratamento de um paciente que sofre de um distúrbio sanguíneo e plaquetas de sangue fixas secas por atomização tendo geometria com cavidades esféricas" |
| DK3266463T3 (da) * | 2009-06-09 | 2024-01-08 | Prolong Pharmaceuticals Llc | Hæmoglobinsammensætninger |
| US8808748B2 (en) * | 2010-04-20 | 2014-08-19 | Vindico NanoBio Technology Inc. | Biodegradable nanoparticles as novel hemoglobin-based oxygen carriers and methods of using the same |
| US20120028899A1 (en) | 2010-07-30 | 2012-02-02 | Andre Francis Palmer | Composition and process for synthesizing tense and relaxed state polymerized hemoglobin |
| US8609815B2 (en) | 2010-09-02 | 2013-12-17 | Sangart, Inc. | Methods for preparing stable deoxygenated PEG-hemoglobin conjugate solutions comprising an antioxidant |
| US10426820B2 (en) | 2011-04-13 | 2019-10-01 | Case Western Reserve University | Synthetic platelets |
| WO2014033208A1 (en) | 2012-08-30 | 2014-03-06 | Qiagen Gmbh | A method for obtaining blood plasma from a whole blood sample |
| US9304142B1 (en) | 2013-03-12 | 2016-04-05 | A. Steve Gurganian | Energy harvesting zero-speed sensor device, method and system |
| JP6461005B2 (ja) * | 2013-11-21 | 2019-01-30 | 協和メデックス株式会社 | 血清又は血漿中の低密度リポ蛋白の凍結乾燥による変性抑制剤及び変性抑制方法 |
| AU2015301014B2 (en) * | 2014-08-08 | 2021-05-06 | Poseida Therapeutics, Inc. | Compositions and methods for inducing nanoparticle-mediated microvascular embolization of tumors |
| EP3849570A4 (en) * | 2018-09-11 | 2023-07-12 | Cellphire Inc. | Blood plasma-containing compositions |
| CA3143968A1 (en) * | 2019-07-02 | 2021-02-25 | Hbo2 Therapeutics, Llc | Hemoglobin substitute mixtures including reconstituted plasma and platelets and their manufacture and use |
| US20210023140A1 (en) | 2019-07-26 | 2021-01-28 | Prp Scientific, Inc. | Platelet formulations and medical uses thereof |
-
2021
- 2021-06-23 JP JP2022579666A patent/JP2023531508A/ja active Pending
- 2021-06-23 ES ES21830096T patent/ES3073540T3/es active Active
- 2021-06-23 CA CA3183555A patent/CA3183555A1/en active Pending
- 2021-06-23 AU AU2021297879A patent/AU2021297879A1/en active Pending
- 2021-06-23 EP EP26169953.2A patent/EP4782058A2/en active Pending
- 2021-06-23 EP EP21830096.0A patent/EP4167961B1/en active Active
- 2021-06-23 WO PCT/US2021/038606 patent/WO2021262803A1/en not_active Ceased
- 2021-06-23 US US18/002,806 patent/US20230241184A1/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2841099T3 (es) | Soluciones a base de bicarbonato para terapias de diálisis | |
| CN1142781C (zh) | 9－脱氧－2′,9－α－亚甲基－3－氧杂－4,5,6－三去甲－3,7－(1′,3′－间亚苯基)－13,14－二氢－前列腺素F1在治疗外周血管疾病中的用途 | |
| US5439882A (en) | Blood substitute | |
| ES2302350T3 (es) | Combinacion sinergica de inhibidores de pde y agonistas de adenilatociclasa o agonistas de guanililciclasa. | |
| TW200422045A (en) | Biocompatible dialysis fluids containing icodextrins | |
| US10471175B2 (en) | Wound spray | |
| Hercz et al. | Prevention of phosphate retention and hyperphosphatemia in uremia. | |
| JP6425661B2 (ja) | 透析組成物 | |
| CN105380941A (zh) | 苯酞类化合物药物用途及其医药组合物 | |
| JPS5841814A (ja) | 抗レ−シユマニア症薬剤組成物およびその製造法 | |
| Standl | Haemoglobin-based erythrocyte transfusion substitutes | |
| US4185093A (en) | Preparation and method for treatment of hypocalcemia, hypophosphatemia and downer cow syndrome in animals | |
| JP3930250B2 (ja) | ヘモクロマトーシス治療のためのエリトロポエチンの使用 | |
| Frietsch et al. | Artificial oxygen carriers | |
| CZ302750B6 (cs) | Farmaceutická kompozice a ampulka na bázi erythropoietinu a zpusob inhibování mikrobiálního rustu v roztoku obsahujícím tuto látku | |
| KR20160091918A (ko) | 저반응성 환자에서 에리스로포이에틴 자극제의 용량을 감소시키는 방법 | |
| Standl | Artificial oxygen carriers as red blood cell substitutes–perfluorocarbons and cell-free hemoglobin | |
| Ogata | Evaluation of human hemoglobin vesicle as an oxygen carrier: recovery from hemorrhagic shock in rabbits | |
| CA2103680C (en) | Improved blood substitute | |
| CA1239586A (en) | Dialysis solution containing amino acids | |
| CA3171518A1 (en) | Compositions and methods for treating or preventing multiple organ dysfunction syndrome | |
| Yatzidis et al. | On the usefulness of glycylglycine in hemodialysis and peritoneal dialysis solutions | |
| CN1379676A (zh) | 血浆代用品组合物 | |
| JP3479915B2 (ja) | ヘモグロビン内包脂質小胞体 | |
| RU2012334C1 (ru) | Состав для профиликтики и лечения железодефицитной анемии |